RAPT Therapeutics Stock Soars 10.28% on Bullish Analyst Targets

On March 27, 2025, RAPT Therapeutics' stock surged by 10.28% in pre-market trading, indicating a strong start to the day's trading session.

RAPT Therapeutics has seen a range of price targets from analysts, with forecasts varying from a low of $2.00 to a high of $10.00. The average price target suggests a significant increase of 303.36% from the last closing price of $1.19, reflecting optimism about the company's future prospects.

Analysts have also provided earnings estimates for RAPT Therapeutics, with expectations that the company's earnings will improve next year. The trailing EPS stands at -$3.11, and analysts predict a reduction in losses from ($2.14) to ($1.35) per share, indicating a positive trend in the company's financial performance.